Explore more topics
SEC Form 4 research

Neurogene Inc. insider transactions

Inspect Neurogene Inc.'s public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001404644
Reporting owners
54
Officers and directors
13
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 0 rows, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Show the table · 20 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

Jordan Julie00019685545
McMinn Rachel000160630218
Walkey Carl000184318926
DRACHMAN JONATHAN G000158846725
667, L.P.00015511392,118
Alam Kamran00016000461
Baker Bros. Advisors (GP) LLC00015805752,197
BAKER BROS. ADVISORS LP00012635082,370
Baker Brothers Life Sciences LP00013633642,127
BAKER FELIX00010879404,174
BAKER JULIAN00010879394,416
Cobb Stuart00019943014
Cvijic Christine Mikail000154366314
Ho Robert00018062541
LEVITT DANIEL J00012787112
MacKenzie Lloyd00016001642
Main David00015999413
Mitchell David Chilton00016276842
Patel Priti00018599973
Smith Sean Michael00019147693
Jordan Julie ↗McMinn Rachel ↗Walkey Carl ↗DRACHMAN JONATHAN G ↗667, L.P. ↗Alam Kamran ↗Baker Bros. Advisors (GP) LLC ↗BAKER BROS. ADVISORS LP ↗Baker Brothers Life Sciences LP ↗BAKER FELIX ↗BAKER JULIAN ↗Cobb Stuart ↗Cvijic Christine Mikail ↗Ho Robert ↗LEVITT DANIEL J ↗MacKenzie Lloyd ↗Main David ↗Mitchell David Chilton ↗Patel Priti ↗Smith Sean Michael ↗

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.